How real estate can accelerate productivity as life sciences companies prioritize COVID-19 therapeutics, vaccines, and new diagnostics R&D amidst new guidelines.
Roger Humphrey
Advertisement
Roger Humphrey is executive managing director of JLL Life Sciences.
Articles by Roger Humphrey
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies. JLL’s 2015 Life Sciences Outlook report highlights global clusters worth watching.
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies. JLL’s 2015 Life Sciences Outlook report highlights global clusters worth watching.
Trends in real estate and facility clusters give insight into the state of the biopharmaceutical industry.
Advertisement
Latest Updated Articles
Global Biopharma Industry Shifts Echoed in Real Estate and Facilities ClustersPublished: September 15th 2014 | Updated:
- Emerging Life-Sciences Markets: New Partnerships, New Competitors
Published: October 2nd 2015 | Updated:
Emerging Life-Sciences Markets: New Partnerships, New CompetitorsPublished: October 2nd 2015 | Updated:
Advertisement
Advertisement
